Wistar immunologists awarded grants to promote the development of vaccinesagainst HIV-1 and human papilloma viruses
Researchers at The Wistar Institute are developing vaccines targeting the mucosal immune system to prevent HIV-1 and human papilloma virus infections. They aim to induce neutralizing antibodies and killer T cells to prevent cancerous transformations in cells, with a focus on cervical cancer caused by HPV.